Respiratory mortality in chronic obstructive pulmonary disease: fixed ratio versus lower limit of normal in smokers

Authors:

Abstract
No abstract available
Funding Information
  • National Heart, Lung, and Blood Institute
  • National Heart, Lung, and Blood Institute (R01 HL151421)
  • National Heart, Lung, and Blood Institute (K01HL163249)
  • The COPDGene study (NCT00608764)
  • National Heart, Lung, and Blood Institute (U01HL089897)
  • National Heart, Lung, and Blood Institute (U01HL089856)
  • National Institutes of Health (75N92023D00011)
  • COPD Foundation
  • Industry Advisory Committee
  • AstraZeneca
  • Bayer Pharmaceuticals
  • Boehringer-Ingelheim
  • Genentech Foundation
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Sunovion

This publication has 12 references indexed in Scilit: